Tesamorelin

Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone, abbreviated GHRH. Its structure contains 44 amino acid residues with an N-terminal chemical modification. QURE lists tesamorelin as a 10mg research product.

The peptide’s length and modified terminus are useful identifying characteristics when comparing it with other GHRH-related materials. A shared reference to GHRH does not establish that two compounds have the same sequence, terminal chemistry, or molecular specification. Tesamorelin should be documented under its own compound name.

This larger peptide is structurally distinct from ipamorelin, a five-residue peptide also found in the QURE catalog. The products should not be considered equivalents because they appear in overlapping areas of scientific literature.

The listed 10mg identifies QURE’s product quantity. It is not a description of a finished medicinal formulation, a prepared solution concentration, or a laboratory procedure. Published information about tesamorelin concerns the compound in the reported context and does not certify a separately supplied research lot.

Material-specific documentation should be reviewed independently of this chemical overview. Consult the certificate of analysis library for current listings and request clarification of any specification needed for your records. No body-composition, hormone-response, or therapeutic claim is made for this research product.

For research use only. Not for human or veterinary use, consumption, or administration.